Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Bizhen Lin"'
Autor:
Xingmei Yao, Wengang He, Xianghong Wu, Jianxiang Gu, Jing Zhang, Bizhen Lin, Zhaofeng Bi, Yingying Su, Shoujie Huang, Yuemei Hu, Ting Wu, Jun Zhang, Ningshao Xia
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
The study assessed long-term immunopersistence and safety of the Escherichia coli (E. coli)-produced HPV-16/18 bivalent vaccine. In total, 979 participants in the initial immunogenicity noninferiority study, including girls aged 9-14 years who were r
Externí odkaz:
https://doaj.org/article/bd3c4a04d89f416c97bc94384f9686b2
Autor:
Xingmei Yao, Wen Chen, Chao Zhao, Lihui Wei, Yuemei Hu, Mingqiang Li, Zhijie Lin, Bizhen Lin, Xiaohui Liu, Ying Hong, Qing Li, Qinjing Pan, Xun Zhang, Mingzhu Li, Yuqian Zhao, Li Zhang, Huifang Xu, Fangfang Hu, Jun Zhao, Yue Huang, Wei Sheng, Ya Zheng, Shangying Hu, Yingying Su, Shoujie Huang, Huirong Pan, Fanghui Zhao, Youlin Qiao, Ting Wu, Jun Zhang, Ningshao Xia
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 13, Iss , Pp 100196- (2021)
Summary: Background: Although recent studies have suggested that naturally acquired Human papillomavirus (HPV) antibodies are partly protective against subsequent homotypic infection, the extent of protection remains indecisive. Here, we evaluate the
Externí odkaz:
https://doaj.org/article/af023f77267847b2978357d5f38d3357
Autor:
Yue Zhang, Shengdi Xia, Wen-xia Shi, Bizhen Lin, Xiao-can Su, Weiwei Lu, Xinyuan Wu, Xuan Wang, Xiaojie Lu, Ming Yan, Xue-jing Zhang
Publikováno v:
Organic Letters. 24:7961-7966
The photocatalyst-free electron donor-acceptor (EDA) complex photochemistry was deemed to expand the potential of photodriven radical chemistry. Here, we report a cross-coupling reaction of thianthrenium salt functionalized arenes and sodium sulfinat
Autor:
Xingmei Yao, Kai Chu, Jun Zhao, Yuemei Hu, Zhijie Lin, Bizhen Lin, Qi Chen, Yafei Li, Qiufen Zhang, Mujin Fang, Shoujie Huang, Yingbin Wang, Yingying Su, Ting Wu, Jun Zhang, Ningshao Xia
Publikováno v:
Future microbiology. 17
Aims: To analyze the consistency between HPV-neutralizing antibodies and specific total IgG antibodies in unvaccinated females. Materials & methods: Serum samples from 978 unvaccinated Chinese females aged 9–26 years were measured for antibodies ag
Publikováno v:
Molecular Plant Breeding.
Autor:
Yingying Su, Bizhen Lin, Sijie Zhuang, Shoujie Huang, Hui Zhao, Juan Li, Rong-Cheng Li, You-Lin Qiao, Changgui Li, Guang Sun, Zizheng Zheng, Huirong Pan, Yuemei Hu, Zhijie Lin, Lihui Wei, Jun Zhang, Ting Wu
Publikováno v:
Hum Vaccin Immunother
An Escherichia. coli-produced HPV-16/18 bivalent vaccine has been proved to be well-tolerated and highly efficacious against diseases associated with vaccine HPV types. As a part of the multi-center, randomized, double-blind phase III clinical trial,
Autor:
Feixue Wei, Bizhen Lin, Jing Zhang, Yuemei Hu, Zhijie Lin, Yingying Su, Fengcai Zhu, Ningshao Xia, Yafei Li, Meng Guo, Jian-Xiang Gu, Juan Li, Yue Huang, Wen-Gang He, Kai Chu, Shoujie Huang, Xiang-Hong Wu, Hui Zhao, Changgui Li, Jun Zhang, Xingmei Yao, Ting Wu, Huirong Pan
Publikováno v:
Science China. Life Sciences
A new HPV-16/18 bivalent vaccine expressed by the Escherichia coli has been proven to be efficacious in adult women. A randomized, immunogenicity noninferiority study of this candidate vaccine was conducted in December 2015 in China. Girls aged 9–1
Autor:
Ting Wu, Zhijie Lin, Fengcai Zhu, Shoujie Huang, Huirong Pan, Yuemei Hu, Lingxian Qiu, Xiao-Hui Liu, Fangfang Hu, Zhao-Feng Bi, Tianying Zhang, You-Lin Qiao, Jun Zhang, Bizhen Lin, Yingying Su, Chunlan Zhuang, Ningshao Xia
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Concerns about vaccine safety are an important reason for vaccine hesitancy, however, limited information is available on whether common adverse reactions following vaccination affect the immune response. Data from three clinical trials of recombinan
Autor:
Shoujie Huang, Bizhen Lin, Fang-Hui Zhao, Ying Hong, Yuqian Zhao, Ningshao Xia, Yue Huang, Xiao-Hui Liu, Yingying Su, Ya Zheng, Wen Chen, Huirong Pan, Chao Zhao, Huifang Xu, Qin-Jing Pan, Wei Sheng, Mingqiang Li, Yuemei Hu, Jun Zhao, Xun Zhang, Qing X. Li, You-Lin Qiao, Fangfang Hu, Shang-Ying Hu, Li-hui Wei, Mingzhu Li, Zhijie Lin, Jun Zhang, Xingmei Yao, Ting Wu, Li Zhang
Publikováno v:
SSRN Electronic Journal.
Background: Currently, knowledge of the protective effects of natural acquired immunity against human papillomavirus (HPV) is mostly based on studies using binding antibodies (IgG) as biomarkers due to the labor-consuming characteristics of neutraliz
Autor:
Xiaojuan Yu, Jun Zhang, Changgui Li, Bizhen Lin, Ting Wu, Zhijie Lin, Lihui Wei, Wei-Dan Huang, Hui Zhao, Yuemei Hu, Shoujie Huang, You-Lin Qiao, Rong-Cheng Li, Huirong Pan, Juan Li
Publikováno v:
Hum Vaccin Immunother
A new Escherichia coli-produced human papillomavirus (HPV)-16/18 vaccine has been shown to be safe and highly efficacious and was recently licensed in China. As a post hoc analysis of the phase III trial, this study aimed to assess the impact of vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::923d328c1710a4cf10716d54510d1fd5
https://europepmc.org/articles/PMC7482734/
https://europepmc.org/articles/PMC7482734/